tiprankstipranks
Trending News
More News >
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
US Market

RVL Pharmaceuticals (RVLPQ) Income Statement

Compare
311 Followers

RVL Pharmaceuticals Income Statement

Last quarter (Q2 2023), RVL Pharmaceuticals's total revenue was $8.26M, a decrease of -2.25% from the same quarter last year. In Q2, RVL Pharmaceuticals's net income was $-23.89M. See RVL Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 49.72M$ 17.50M$ 27.76M$ 240.03M$ 263.70M
Gross Profit
$ 40.27M$ 13.88M$ 24.47M$ 128.40M$ 121.75M
Operating Expenses
$ 99.25M$ 96.64M$ 86.21M$ 125.35M$ 116.06M
Depreciation and Amortization
$ 375.00K$ 8.18M$ 21.03M$ 57.02M$ 81.60M
EBITDA
$ -48.23M$ -71.32M$ -69.67M$ -222.80M$ -16.28M
Operating Income
$ -58.99M$ -78.71M$ -61.74M$ -280.69M$ 5.68M
Other Income/Expenses
$ 7.28M$ -3.82M$ -33.05M$ -17.33M$ -20.13M
Pretax Income
$ -51.71M$ -82.53M$ -94.80M$ -298.02M$ -118.66M
Net Income
$ -51.69M$ -64.92M$ -79.59M$ -270.90M$ -109.68M
Per Share Metrics
Basic EPS
$ -0.58$ -0.96$ -1.31$ -5.17$ -2.42
Diluted EPS
$ -0.58$ -0.96$ -1.31$ -5.17$ -2.42
Weighted Average Shares Outstanding
89.80M 67.35M 60.65M 52.37M 45.28M
Weighted Average Shares Outstanding (Diluted)
89.80M 67.35M 60.65M 52.37M 45.28M
Currency in USD

RVL Pharmaceuticals Earnings and Revenue History